Polish pharma leader adamed joins €15m series a for one biosciences to accelerate aipowered precision oncology breakthroughs in a major win for poland’s growing presence in the global healthtech scene, adamed, one of the country’s leading pharmaceutical and biotechnology companies, has joined an elite group of investors backing one biosciences, a french biotech startup revolutionizing.
Cât de protejată este România în noul context de securitate europeană aflăm de la expertul în geopolitică Dorin Popescu.
Publicat de Adina Sîrbu, 9 martie 2026, 17:44
